Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Development of a hamster model for hepatitis B virus infection

Award Number: R01AI183883
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/09/2024
PERIOD OF PERFORMANCE END DATE: 07/31/2029

Group Awards By:

View Award Description

Development of a hamster model for hepatitis B virus infection - PROJECT SUMMARY Hepatitis B virus (HBV) has infected more than one-third of the world’s population and that almost 296 million people are currently living with chronic infection including over 6 million children under the age of five. Each year, about 1.5 million people become newly infected and 820,000 people die from HBV infection and related complications. Therapeutics for HBV are available, but they hardly lead to a functional cure for chronic HBV infection. One of the biggest challenges in developing an HBV cure is the lack of immunocompetent animal models that are susceptible to HBV infection and support the entire life cycle of HBV. HBV has an extremely narrow host tropism, determined both by species-specific host cellular viral entry receptor, sodium taurocholate co-transporting peptide (NTCP), and the host factors needed to support the lifecycle of HBV post viral entry. HBV transgenic mice do not support the formation of viral covalently closed circular DNA (cccDNA), the bona fide viral transcription template, via the intracellular cccDNA amplification mechanism; genetically modified mice carrying human NTCP fail to establish HBV infection due to the failure of de novo cccDNA formation. In search of other laboratory animal species-derived hepatocytes that may support HBV cccDNA formation, our preliminary studies demonstrated that Ad-HBV-transduced primary hamster hepatocytes (PHaHs) are capable of supporting HBV DNA replication and cccDNA formation, and Ad-hNTCP-transduced PHaH cells are susceptible to HBV infection. Hence, the objective of this project is to establish a novel Syrian hamster (Mesocricetus auratus) model that is tractable, fully immunocompetent, and highly susceptible for HBV infection. To this end, we will pursue the following Specific Aims: Aim 1. Establish a humanized-NTCP (huNTCP) hamster model for HBV infection. We will use the validated CRISPR-mediated gene editing techniques developed by us in the hamster to humanize the two codons encoding the key amino acid residues in the hamster NTCP protein required for HBV infection. Aim 2. Establish acute and chronic infection in the huNTCP hamsters and characterize the pathogenesis and humoral immune responses to HBV. Under this Aim, we will infect huNTCP hamsters to establish acute and chronic HBV infections and carry out pathogenesis studies. We will also carry out studies to characterize the humoral responses during acute and chronic infections. Aim 3. Test direct-acting antivirals (DAAs), immunoregulators and epigenetic modifiers in suppressing HBV infection in the huNTCP hamster model. We will test the utility of this immunocompetent huNTCP hamster model in assessing the efficacies of a selected panel of anti-HBV drugs with different HBV-inhibiting mechanisms, including a direct acting antiviral (DAA), tenofovir (TDF), an immunoregulator, IFNalpahcon-1, and an epigenetic modifier, MS436, in suppressing chronic HBV infection. We envision that this novel hamster model will greatly facilitate the development of new therapeutics that are needed to achieve a functional cure for HBV.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $728,653 )
2025	2025	UTAH STATE UNIVERSITY	1000 OLD MAIN HL	LOGAN	UT	84322	CACHE	USA	Allergy and Infectious Diseases Research	000	2	8/5/2025	NON-COMPETING CONTINUATION	$728,653
														Subtotal = $728,653

Issue Date FY: 2024 ( Subtotal = $756,589 )
2024	2024	UTAH STATE UNIVERSITY	1000 OLD MAIN HL	LOGAN	UT	84322	CACHE	USA	Allergy and Infectious Diseases Research	000	1	8/9/2024	NEW	$756,589
														Subtotal = $756,589

Grand Total All Awards = $1,485,242

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Development of a hamster model for hepatitis B virus infection

Award Number: R01AI183883

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/09/2024

PERIOD OF PERFORMANCE END DATE: 07/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer